Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making

<i>Background</i>: age structured mathematical models have been used to evaluate the impact of rubella-containing vaccine (RCV) introduction into existing measles vaccination programs in several countries. South Africa has a well-established measles vaccination program and is considering...

Full description

Bibliographic Details
Main Authors: Nkengafac Villyen Motaze, Ijeoma Edoka, Charles S. Wiysonge, C. Jessica E. Metcalf, Amy K. Winter
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/8/3/383
_version_ 1797416770589425664
author Nkengafac Villyen Motaze
Ijeoma Edoka
Charles S. Wiysonge
C. Jessica E. Metcalf
Amy K. Winter
author_facet Nkengafac Villyen Motaze
Ijeoma Edoka
Charles S. Wiysonge
C. Jessica E. Metcalf
Amy K. Winter
author_sort Nkengafac Villyen Motaze
collection DOAJ
description <i>Background</i>: age structured mathematical models have been used to evaluate the impact of rubella-containing vaccine (RCV) introduction into existing measles vaccination programs in several countries. South Africa has a well-established measles vaccination program and is considering RCV introduction. This study aimed to provide a comparison of different scenarios and their relative costs within the context of congenital rubella syndrome (CRS) reduction or elimination. <i>Methods</i>: we used a previously published age-structured deterministic discrete time rubella transmission model. We obtained estimates of vaccine costs from the South African medicines price registry and the World Health Organization. We simulated RCV introduction and extracted estimates of rubella incidence, CRS incidence and effective reproductive number over 30 years. <i>Results</i>: compared to scenarios without mass campaigns, scenarios including mass campaigns resulted in more rapid elimination of rubella and congenital rubella syndrome (CRS). Routine vaccination at 12 months of age coupled with vaccination of nine-year-old children was associated with the lowest RCV cost per CRS case averted for a similar percentage CRS reduction. <i>Conclusion</i>: At 80% RCV coverage, all vaccine introduction scenarios would achieve rubella and CRS elimination in South Africa. Any RCV introduction strategy should consider a combination of routine vaccination in the primary immunization series and additional vaccination of older children.
first_indexed 2024-03-09T06:09:00Z
format Article
id doaj.art-025aedd80ed2419caeb0d664c13c851e
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-09T06:09:00Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-025aedd80ed2419caeb0d664c13c851e2023-12-03T11:59:59ZengMDPI AGVaccines2076-393X2020-07-018338310.3390/vaccines8030383Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision MakingNkengafac Villyen Motaze0Ijeoma Edoka1Charles S. Wiysonge2C. Jessica E. Metcalf3Amy K. Winter4Centre for Vaccines and Immunology, National Institute for Communicable Diseases/National Health Laboratory Service, Johannesburg 2131, South AfricaSouth African Medical Research Council Centre for Health Economics and Decision Science-PRICELESS SA, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South AfricaDepartment of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town 7505, South AfricaDepartment of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ 08544, USADepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA<i>Background</i>: age structured mathematical models have been used to evaluate the impact of rubella-containing vaccine (RCV) introduction into existing measles vaccination programs in several countries. South Africa has a well-established measles vaccination program and is considering RCV introduction. This study aimed to provide a comparison of different scenarios and their relative costs within the context of congenital rubella syndrome (CRS) reduction or elimination. <i>Methods</i>: we used a previously published age-structured deterministic discrete time rubella transmission model. We obtained estimates of vaccine costs from the South African medicines price registry and the World Health Organization. We simulated RCV introduction and extracted estimates of rubella incidence, CRS incidence and effective reproductive number over 30 years. <i>Results</i>: compared to scenarios without mass campaigns, scenarios including mass campaigns resulted in more rapid elimination of rubella and congenital rubella syndrome (CRS). Routine vaccination at 12 months of age coupled with vaccination of nine-year-old children was associated with the lowest RCV cost per CRS case averted for a similar percentage CRS reduction. <i>Conclusion</i>: At 80% RCV coverage, all vaccine introduction scenarios would achieve rubella and CRS elimination in South Africa. Any RCV introduction strategy should consider a combination of routine vaccination in the primary immunization series and additional vaccination of older children.https://www.mdpi.com/2076-393X/8/3/383rubellacongenital rubella syndromerubella-containing vaccinevaccine introduction strategiesage-structured rubella transmission model
spellingShingle Nkengafac Villyen Motaze
Ijeoma Edoka
Charles S. Wiysonge
C. Jessica E. Metcalf
Amy K. Winter
Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
Vaccines
rubella
congenital rubella syndrome
rubella-containing vaccine
vaccine introduction strategies
age-structured rubella transmission model
title Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
title_full Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
title_fullStr Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
title_full_unstemmed Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
title_short Rubella Vaccine Introduction in the South African Public Vaccination Schedule: Mathematical Modelling for Decision Making
title_sort rubella vaccine introduction in the south african public vaccination schedule mathematical modelling for decision making
topic rubella
congenital rubella syndrome
rubella-containing vaccine
vaccine introduction strategies
age-structured rubella transmission model
url https://www.mdpi.com/2076-393X/8/3/383
work_keys_str_mv AT nkengafacvillyenmotaze rubellavaccineintroductioninthesouthafricanpublicvaccinationschedulemathematicalmodellingfordecisionmaking
AT ijeomaedoka rubellavaccineintroductioninthesouthafricanpublicvaccinationschedulemathematicalmodellingfordecisionmaking
AT charlesswiysonge rubellavaccineintroductioninthesouthafricanpublicvaccinationschedulemathematicalmodellingfordecisionmaking
AT cjessicaemetcalf rubellavaccineintroductioninthesouthafricanpublicvaccinationschedulemathematicalmodellingfordecisionmaking
AT amykwinter rubellavaccineintroductioninthesouthafricanpublicvaccinationschedulemathematicalmodellingfordecisionmaking